Jan 10, 2024 / 03:30PM GMT
Edwin Zhang JPMorgan Chase&Co.-Analyst
Good morning. Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is Edwin Zang. I'm a member of the JPMorgan Health Care team and your moderator for this session today. I would like to introduce you to the team from Alpine Immune Sciences. Please join me in welcoming our presenter, Mitchell Gold, who is the Chairman and CEO of Alpine.
Mitchell Gold - Alpine Immune Sciences Inc - Executive Chairman of the Board, Chief Executive Officer
Thanks, Andrew. And I would like to remind you that I will be making forward-looking statements during the course of my presentation today, and I encourage you to refer to most recent SEC filings regarding the risk factors associated with these statements. Since our five since our founding Alpha has been passionate about using our directed evolution platform to create novel protein structures and novel molecules that can dramatically transform health care. It improves patients' lives suffering from debilitating diseases. We believe we've accomplished
Alpine Immune Sciences Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
